Craniopharyngioma
Oncology·MeSH: Craniopharyngioma
Prevalence
5.0 / 100K
1 drug in development·1 company·4 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ^1^1c-methionine | GH Research PLC (GHRS) |
Frequently asked questions
How many drugs are in development for Craniopharyngioma?
BioSniper tracks 1 drug in development for Craniopharyngioma across 1 company.
How many clinical trials target Craniopharyngioma?
There are 4 clinical trials targeting Craniopharyngioma tracked by BioSniper.
What is the prevalence of Craniopharyngioma?
The estimated prevalence of Craniopharyngioma is approximately 5.0 per 100,000 population.
Deep-dive into Craniopharyngioma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis